Skip Over Navigation Links
National Institutes of Health
:
Find more NIMH pages about: Medications

Science News about Medications

Find Press Releases and Science Updates by Topic

Not All Antipsychotics Created Equal: Analysis Reveals Important Differences
December 9, 2008 • Science Update
An analysis of studies on antipsychotics reveals multiple differences among the newer, second-generation antipsychotics as well as the older medications, and suggests the current classification system blurs important differences.
Cells May Provide Target for New Anxiety Medications
November 6, 2008 • Science Update
A specific population of brain cells could provide a target for developing new medications aimed at helping people learn to mute the fears underlying anxiety disorders, according to NIMH-supported scientists.
Symptoms Persist as Bipolar Children Grow Up
October 27, 2008 • Science Update
Bipolar disorder (BD) identified in childhood often persisted into adulthood in the first large follow-up study of its kind. Forty-four percent of children diagnosed with BD continued to have manic episodes as adults, in the study by NIMH grantee Barbara Geller, M.D.
Certain Antipsychotic Medications May Increase Risk for Heart Disease
October 16, 2008 • Science Update
Certain atypical antipsychotic medications may raise the risk for heart disease in people with schizophrenia.
Millisecond Brain Signals Predict Response to Fast-Acting Antidepressant
October 2, 2008 • Press Release
Images of the brain’s fastest signals reveal an electromagnetic marker that predicts a patient’s response to a fast-acting antidepressant, researchers have discovered.
Newer Antipsychotics No Better Than Older Drug in Treating Child and Adolescent Schizophrenia
September 15, 2008 • Press Release
Two newer atypical antipsychotic medications were no more effective than an older conventional antipsychotic in treating child and adolescent schizophrenia and may lead to more metabolic side effects.
Health Risks Associated with Certain Antipsychotics Warrant Extra Monitoring
July 24, 2008 • Science Update
Some atypical antipsychotics may be more likely than others to cause metabolic and cardiovascular side effects, according to recent analyses using data from the NIMH-funded Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE).
Newer Antipsychotics No Better Than Older Medications in Reducing Schizophrenia-related Violence
July 11, 2008 • Science Update
Antipsychotic medications can reduce the risk of violence among people with schizophrenia, but the newer atypical antipsychotics are no more effective in doing so than older medications.
Paying More for Prescriptions May Limit Seniors’ Access to Antidepressants
April 2, 2008 • Science Update
New cost-sharing policies may prevent some older adults diagnosed with depression from filling new antidepressant prescriptions.
State Survey Finds FDA “Black Box” Warning Correlates with Curtailed Antidepressant Prescriptions
March 14, 2008 • Science Update
After the U.S. Food and Drug Administration (FDA) issued a “black box” warning on antidepressant medications, Nebraskan doctors began prescribing fewer antidepressant medications to children and teens and referring more patients to specialists, according to a state survey.
1 | 2 | 3 | 4 | 5 | 6 | 7 | Next >